242 related articles for article (PubMed ID: 35194809)
1. Quantitative analysis of dose-averaged linear energy transfer (LET
Rana S; Traneus E; Jackson M; Tran L; Rosenfeld AB
Med Phys; 2022 May; 49(5):3444-3456. PubMed ID: 35194809
[TBL] [Abstract][Full Text] [Related]
2. Impact of range uncertainty on clinical distributions of linear energy transfer and biological effectiveness in proton therapy.
Hahn C; Eulitz J; Peters N; Wohlfahrt P; Enghardt W; Richter C; Lühr A
Med Phys; 2020 Dec; 47(12):6151-6162. PubMed ID: 33118161
[TBL] [Abstract][Full Text] [Related]
3. Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges.
Hahn C; Heuchel L; Ödén J; Traneus E; Wulff J; Plaude S; Timmermann B; Bäumer C; Lühr A
Radiat Oncol; 2022 Oct; 17(1):169. PubMed ID: 36273132
[TBL] [Abstract][Full Text] [Related]
4. Impact of errors in spot size and spot position in robustly optimized pencil beam scanning proton-based stereotactic body radiation therapy (SBRT) lung plans.
Rana S; Rosenfeld AB
J Appl Clin Med Phys; 2021 Jul; 22(7):147-154. PubMed ID: 34101334
[TBL] [Abstract][Full Text] [Related]
5. Dose averaged linear energy transfer optimization for large sacral chordomas in carbon ion therapy.
Schafasand M; Resch AF; Nachankar A; Góra J; Martino G; Traneus E; Glimelius L; Georg D; Fossati P; Carlino A; Stock M
Med Phys; 2024 May; ():. PubMed ID: 38696546
[TBL] [Abstract][Full Text] [Related]
6. Small spot size versus large spot size: Effect on plan quality for lung cancer in pencil beam scanning proton therapy.
Rana S; Rosenfeld AB
J Appl Clin Med Phys; 2022 Feb; 23(2):e13512. PubMed ID: 34989458
[TBL] [Abstract][Full Text] [Related]
7. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors.
Ödén J; Toma-Dasu I; Witt Nyström P; Traneus E; Dasu A
Med Phys; 2020 Feb; 47(2):342-351. PubMed ID: 31705671
[TBL] [Abstract][Full Text] [Related]
8. Technical note: Investigation of dose and LET
Yang Y; Rwigema JM; Vargas C; Yu NY; Keole SR; Wong WW; Schild SE; Bues M; Liu W; Shen J
Med Phys; 2022 Dec; 49(12):7428-7437. PubMed ID: 36208196
[TBL] [Abstract][Full Text] [Related]
9. Pencil beam scanning proton therapy for the treatment of craniopharyngioma complicated with radiation-induced cerebral vasculopathies: A dosimetric and linear energy transfer (LET) evaluation.
Bolsi A; Placidi L; Pica A; Ahlhelm FJ; Walser M; Lomax AJ; Weber DC
Radiother Oncol; 2020 Aug; 149():197-204. PubMed ID: 32387488
[TBL] [Abstract][Full Text] [Related]
10. Proton monoenergetic arc therapy (PMAT) to enhance LETd within the target.
Bertolet A; Carabe A
Phys Med Biol; 2020 Aug; 65(16):165006. PubMed ID: 32428896
[TBL] [Abstract][Full Text] [Related]
11. The dirty and clean dose concept: Towards creating proton therapy treatment plans with a photon-like dose response.
Heuchel L; Hahn C; Ödén J; Traneus E; Wulff J; Timmermann B; Bäumer C; Lühr A
Med Phys; 2024 Jan; 51(1):622-636. PubMed ID: 37877574
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated proton therapy (IMPT) interplay effect evaluation of asymmetric breathing with simultaneous uncertainty considerations in patients with non-small cell lung cancer.
Shan J; Yang Y; Schild SE; Daniels TB; Wong WW; Fatyga M; Bues M; Sio TT; Liu W
Med Phys; 2020 Nov; 47(11):5428-5440. PubMed ID: 32964474
[TBL] [Abstract][Full Text] [Related]
13. FRoG: An independent dose and LET
Kopp B; Fuglsang Jensen M; Mein S; Hoffmann L; Nyström H; Falk M; Haberer T; Abdollahi A; Debus J; Mairani A
Med Phys; 2020 Oct; 47(10):5274-5286. PubMed ID: 32737870
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of the LETd-weighted biological dose in the evaluation of breast intensity-modulated proton therapy plans.
Liu C; Zheng D; Bradley JA; Mailhot Vega RB; Zhang Y; Indelicato DJ; Mendenhall N; Liang X
Acta Oncol; 2021 Feb; 60(2):252-259. PubMed ID: 33063569
[TBL] [Abstract][Full Text] [Related]
15. Limited Impact of Setup and Range Uncertainties, Breathing Motion, and Interplay Effects in Robustly Optimized Intensity Modulated Proton Therapy for Stage III Non-small Cell Lung Cancer.
Inoue T; Widder J; van Dijk LV; Takegawa H; Koizumi M; Takashina M; Usui K; Kurokawa C; Sugimoto S; Saito AI; Sasai K; Van't Veld AA; Langendijk JA; Korevaar EW
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(3):661-9. PubMed ID: 27681763
[TBL] [Abstract][Full Text] [Related]
16. Inclusion of a variable RBE into proton and photon plan comparison for various fractionation schedules in prostate radiation therapy.
Ödén J; Eriksson K; Toma-Dasu I
Med Phys; 2017 Mar; 44(3):810-822. PubMed ID: 28107554
[TBL] [Abstract][Full Text] [Related]
17. Superiority in Robustness of Multifield Optimization Over Single-Field Optimization for Pencil-Beam Proton Therapy for Oropharynx Carcinoma: An Enhanced Robustness Analysis.
Stützer K; Lin A; Kirk M; Lin L
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):738-749. PubMed ID: 29280468
[TBL] [Abstract][Full Text] [Related]
18. Interlaced proton grid therapy - Linear energy transfer and relative biological effectiveness distributions.
Henry T; Ödén J
Phys Med; 2018 Dec; 56():81-89. PubMed ID: 30473384
[TBL] [Abstract][Full Text] [Related]
19. An analytical dose-averaged LET calculation algorithm considering the off-axis LET enhancement by secondary protons for spot-scanning proton therapy.
Hirayama S; Matsuura T; Ueda H; Fujii Y; Fujii T; Takao S; Miyamoto N; Shimizu S; Fujimoto R; Umegaki K; Shirato H
Med Phys; 2018 Jul; 45(7):3404-3416. PubMed ID: 29788552
[TBL] [Abstract][Full Text] [Related]
20. The LET trilemma: Conflicts between robust target coverage, uniform dose, and dose-averaged LET in carbon therapy.
Fredriksson A; Glimelius L; Bokrantz R
Med Phys; 2023 Dec; 50(12):7338-7348. PubMed ID: 37820319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
